Utility of tumor marker CA 72.4 in patients with chronic renal failure

International Journal of Biological Markers

Volumn 14, Issue 2, 1999, Pages 118-121

  Gonzalez Vitores A Ma ^a   Encabo Duro G ^a   Bermejo Fraile, B ^a   Olmos Miro A ^a   Armengol Carrasco, M ^a  

^a NONE

Author keywords

CA 72.4; Chronic renal failure; Creatinine

Indexed keywords

CA 72-4 ANTIGEN; CREATININE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; IMMUNORADIOMETRIC ASSAY; MALE; STATISTICAL ANALYSIS; URINARY EXCRETION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 17144457991     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Stragmignini D, Bowen R, Atkinson B, Scholm J. Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas. Int J Cancer 1983; 31: 543-52.
2. Colcher D, Horan Hand P, Nuti P, Scholoms JA. A spectrum of monoclonal antibodies reactive with human inamary tumor cells. Proc Natl Acad Sci USA 1991; 78: 3199-203.
3. Aljama Garcia P, Martín-Malo A, Rodés Teixidor J, Guardia Massó J. Insuficiencia renal cronica. Medicina Interna 1997; II: 2321.
4. Barrio V. Comite de registro de la SEN. Registro nacional de diálisis y trasplante de la Sociedad Española de Nefrología. Nefrología 1996; 16; 3-24.
5. Miguel Hernandez Bronchud. Manual Molecular del Cancer, 1992; 82-90.
6. a serie 1998; 65: 3040-6.
7. Martin-Pérez E, Fernandez-Arjona M, Baza B, et al. Determinación del marcador tumoral CA 72.4 en el carcinoma gástrico. Hospital de la Princesa, Madrid. Rev Esp Enf Digest 1993; 83 (2):92-6.
8. Safi F, Kuhns H, Beger G. Tumor markers in gastric cancer. Current tumor diagnosis: Applications, clinical relevance, research, trends. Cancer of the lung - State and trends in diagnosis and therapy. W. Zuckschwerdt Verlag. München, Bern, Vienna, New York: 1994; 20-7.
9. Hepnert G, Domschke S, Domschke W. Comparison of CA 72.4 with CA 19.9 and CEA in the serum in diagnosis of gastrointestinal cancer. Scand J Gastrointestinal 1989; 24: 745-50.
10. Reiter W, Petra Stieber C, Reiter C, Cramer A, Fatch-Moghandam. CA 72.4, CEA, CA 19.9 in diagnosis of relapse and metastases in prognosis of stomach cancer patients. Current tumor diagnosis: Applications, clinical relevance, research, trends. Cancer of the Lung - State and trends in diagnosis and therapy. München, Bern, Vienna, New York: W. Zuckschwerdt Verlag 1994; 13-6.